Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02054793
Recruitment Status : Withdrawn (This study was never able to open due to lack of funding from the pharmaceutical company.)
First Posted : February 4, 2014
Last Update Posted : July 23, 2014
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Emmanuel Antonarakis, MD, Johns Hopkins University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 2015
Estimated Study Completion Date : July 2016